Preview

Experimental and Clinical Gastroenterology

Advanced search

Significance of genotyping in the diagnosis of arthritis associated with C-viral hepatitis

https://doi.org/10.31146/1682-8658-ecg-187-3-146-151

Abstract

To date, a number of studies have been conducted on the relationship of HCV genotypes with complications such as liver cirrhosis, hepatocellular carcinoma, but research on the correlation of the genotype with extrahepatic clinical manifestations associated with HCV, especially rheumatic manifestations, is insufficient. The purpose of the study is to analyze the most common genotypes of viral hepatitis C in the Republic of Uzbekistan and study their correlation with rheumatic manifestations of HCV. Methods: This study involved 88 patients with HCV infection who received inpatient and subsequent ambulatornoe treatment in Scientific Research Institute of Epidemiology, Microbiology and Infectious diseases of the Republic of Uzbekistan. Diagnostics procedures at the initial level included a set of studies, i. e. clinical, rheumatological and laboratory studies, ultrasound of the joint. In addition, 88 samples of RNA - positive serum from patients diagnosed with HCV were genotyped. Results: the Results showed that genotype 1 of HCV (subtype 1b) is the main genetic variant of HCV in Uzbekistan. Based on the results obtained, the genotypic features of viruses can be markers of the development of extrahepatic clinical manifestations. There is a reliable direct correlation between the incidence and severity of associated arthritis in patients with chronic viral hepatitis C with genotype 1b of the virus according to our research. Conclusions: The results of the study can be provided to help the doctor of the polyclinic service as recommendations that patients with the 1b genotype of the virus have a greater adherence to associated arthritis, and in this case, timely targeted consultation of a specialist is necessary.

About the Authors

F. N. Shukurova
Tashkent medical Academy
Russian Federation


D. A. Parpiboeva
Tashkent medical Academy
Russian Federation


M. Sh. Karimov
Tashkent medical Academy
Russian Federation


References

1. Islambekova Z. A. Measures aiming to decrease hepatitis B and C morbidity rates may help prevent hepatocellular carcinoma in Uzbekistan, Onkologiya. 2009, no. 2, pp. 154-157. (In Russ.)@@ Исламбекова З. А. Снижение заболеваемости в Узбекистане вирусными гепатитами В и С - составляющая профилактики гепатоцеллюлярной карциномы. Онкология. -2009-11 № 2 - С. 154-157.

2. Ananjeva L.P., Ignatova N. V., Smirnov A. V. Chronic erosive seropositive arthritis in a patient with chronic hepatitis C. Rheumatology Science and Practice. 2008;46(1):78-84. (In Russ.) Doi: 10.14412/1995-4484-2008-857

3. Alvarado-Mora M.V, Pinho J. R. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther. 2013, no.18, pp. 429-433.

4. Rosner I., Rozenbaum M., Toubi E., Kessel A., Naschitz J. E., and Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum. 2004, no. 33, pp. 375-387.

5. Muhin N. A., Lopatkina T. N., Ignatova T. M., et al. Vnepechenochnie proyavleniya khronicheskih zabolevaniy pecheni, Klinicheskaya gepatologiya. 2008, no. 4, pp. 34-39. (In Russ.)

6. Baranov A.B., Maleev V. V. Immunologicheskie pokazateli pri hronicheskom techenii gepatita С. nfectious diseases. 2008, vol. 6, no. 1, pp. 13-15. (In Russ.)

7. Nakano T., Lau G. M., Sugiyama M., Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int. 2012, no. 32, pp. 339-345.

8. Poordad F, Dieterich D. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. J Viral Hepat. 2012, no. 19 (7): pp. 449-464.

9. Tanaka Y., Kurbanov F., Mano S., et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology. 2006, no. 130, pp. 703-714.

10. Kurbanov F., Tanaka Y., Sugauchi F., et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol. 2003, no. 69, pp. 367-375.

11. Bazarniy V., et al. Analiz chastoti serologicheskih markyorov virusnih gepatitov u donorov. Kliniko-laboratorniy konsilium. 2010, no. 1, pp. 58-60.

12. Bel’tyukov P. P. Immunologicheskie metodi. Medicinskaya immunologiya. 2005, vol.7, no. 2-3, pp. 272-286.


Review

For citations:


Shukurova F.N., Parpiboeva D.A., Karimov M.Sh. Significance of genotyping in the diagnosis of arthritis associated with C-viral hepatitis. Experimental and Clinical Gastroenterology. 2021;(3):146-151. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-187-3-146-151

Views: 359


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)